Johnson & Johnson (JNJ) vs Meta Platforms, Inc. (META)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Meta Platforms, Inc. is the world’s largest social media company, reaching nearly 4 billion monthly active users globally. Its core business, known as the Family of Apps, includes Facebook, Instagram, Messenger, and WhatsApp. Users rely on these platforms for a wide range of activities, from staying connected with friends and following public figures to operating digital businesses at no cost. Meta monetizes its ecosystem by using customer data generated across its apps to sell advertising to digital marketers. Although the company has invested significantly in Reality Labs, that segment still represents only a small portion of Meta’s total revenue.